Company Filing History:
2 out of 67 
2 out of 11 
2 out of 265 
Years Active: 2019
Title: Anni Rønfeldt Thomsen: Innovator in Prostate Cancer Detection
Introduction
Anni Rønfeldt Thomsen is a notable inventor based in Virum, Denmark. She has made significant contributions to the field of medical diagnostics, particularly in the early detection and prognosis of prostate cancer. With a total of 2 patents, her work is paving the way for advancements in cancer research and patient care.
Latest Patents
Thomsen's latest patents include a microRNA-based method for early detection of prostate cancer in urine samples. This innovative method assesses the risk of prostate cancer by measuring the expression levels of specific microRNAs in urine. Another significant patent focuses on a microRNA-based method for assessing the prognosis of prostate cancer patients, which involves analyzing RNA samples from prostate cells to determine the patient's prognosis based on microRNA expression levels.
Career Highlights
Throughout her career, Anni Rønfeldt Thomsen has worked with esteemed institutions such as Aarhus Universitet and Region Midtjylland. Her research has contributed to the understanding of prostate cancer and the development of diagnostic methods that can improve patient outcomes.
Collaborations
Thomsen has collaborated with notable colleagues, including Karina Dalsgaard Sørensen and Lars Kongsbak. These partnerships have enhanced her research efforts and expanded the impact of her innovations in the medical field.
Conclusion
Anni Rønfeldt Thomsen's work exemplifies the importance of innovation in medical diagnostics, particularly in the fight against prostate cancer. Her contributions are vital for improving early detection and patient prognosis, ultimately leading to better healthcare solutions.